Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aanjaay IndustriesBOM:524322 +6.32%34 Pretax Margin % is 4.01% as of Mar. 2026, which is 122% above its 10-year median of 1.81. GuruFocus rates BOM:524322 with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 960 Drug Manufacturers companies, Aanjaay Industries ranks worse than 53.02% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Aanjaay Industries Pretax Margin % Related Terms
Aanjaay Industries Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Aanjaay Industries's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524322 vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aanjaay Industries's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aanjaay Industries Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aanjaay Industries's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Aanjaay Industries's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aanjaay Industries (BOM:524322) has a Pretax Margin % of 4.01% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Aanjaay Industries and its competitors. This is 122% above median its historical median of 1.81. According to the industry distribution chart, Aanjaay Industries ranks #509 out of 960 companies in the Drug Manufacturers industry, placing it in the top 53%.
Is Aanjaay Industries' Pretax Margin % too high?
Aanjaay Industries' current Pretax Margin % of 4.01% is 122% above median its 10-year median of 1.81. The Drug Manufacturers industry median Pretax Margin % is 7.28. Aanjaay Industries' value of 4.01% is 44.9% below this industry median. Based on the distribution chart, Aanjaay Industries ranks #509 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aanjaay Industries has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Aanjaay Industries' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aanjaay Industries ranks #509 out of 960 companies for Pretax Margin %. This places Aanjaay Industries in the lower half of its industry. The industry median Pretax Margin % is 7.28. Aanjaay Industries' value of 4.01% is 44.9% below this benchmark. While the company's 10-year median is 1.81 vs. the industry median of 7.28, Aanjaay Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aanjaay Industries's current Pretax Margin % of 4.01% is 44.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Aanjaay Industries and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aanjaay Industries's current Pretax Margin % is 4.01%, which is 122% above median its own 10-year median of 1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aanjaay Industries stock overvalued right now?
Aanjaay Industries (BOM:524322) has a current Pretax Margin % of 4.01%. The current Pretax Margin % is 4.01%, which is 122% above median its 10-year median of 1.81 and 44.9% below the Drug Manufacturers industry median of 7.28. Aanjaay Industries' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Aanjaay Industries (BOM:524322), the current Pretax Margin % is 4.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in Permaculture manufacturing and trading in pharmaceutical products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastrointestinal Drugs, and Hormonal Drugs.
34GF Score
Get the complete analysis for BOM:524322
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524322 has been successfully added to your 
